- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glucagon-Like Peptide 2
Total 861 results
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingObesity | Type 2 DiabetesChina
-
University of WashingtonUniversity of Colorado, Denver; Juvenile Diabetes Research Foundation; University... and other collaboratorsRecruitingType 1 Diabetes | Diabetic Kidney DiseaseUnited States, Canada
-
Novo Nordisk A/SActive, not recruitingAlzheimers DiseaseUnited States, Canada, Italy, Sweden, Denmark, Switzerland
-
Novo Nordisk A/SEnrolling by invitationDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SNot yet recruiting
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more
-
University Medical Center GroningenNovo Nordisk A/SCompletedObesity | AlbuminuriaNetherlands, Germany, Spain, Canada
-
Sabyasachi SenCompleted
-
Viral N. ShahJuvenile Diabetes Research FoundationActive, not recruitingObesity | Type 1 DiabetesUnited States
-
University Hospital, Gentofte, CopenhagenMerck Sharp & Dohme LLCCompleted
-
Case Western Reserve UniversityMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingObesity | HIV/AIDS | LipohypertrophyUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Serbia, Italy, Poland, China, Hungary, Saudi Arabia
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Hungary, Brazil, Slovakia
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Peripheral Arterial DiseaseSpain, Taiwan, China, India, United States, Canada, Thailand, Austria, Malaysia, Germany, Poland, Japan, Czechia, Greece, Belgium, Denmark, Hungary, Latvia, Norway, Sweden
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
University of Sao Paulo General HospitalRecruitingType 2 Diabetes Mellitus in Obese | Severe ObesityBrazil
-
Novo Nordisk A/SNot yet recruitingObesityUnited Kingdom, Germany, Canada, United States, France
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer´s DiseaseCanada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
Vanderbilt University Medical CenterNashville VA Medical CenterActive, not recruitingChronic Kidney DiseasesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Denmark, Sweden, Austria
-
Eli Lilly and CompanyLocemia Solutions ULCCompleted
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, South Africa, China, Slovakia
-
Veru Inc.RecruitingObesity | Muscle LossUnited States
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2Thailand, Poland, Czechia, Malaysia, Serbia
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Chronic Kidney DiseaseSpain, United States, Italy, Denmark, Poland, South Africa, Canada, France
-
Novo Nordisk A/SActive, not recruitingObesityUnited States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, India, Taiwan, Poland, Australia, Estonia, Hungary, Germany, Slovakia, Canada, Croatia, Bulgaria, Puerto Rico, Czechia, Slovenia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
University Hospital Bispebjerg and FrederiksbergCompletedDrug Overdose | Overdose of Beta-adrenergic Blocking DrugDenmark
-
Vanderbilt UniversityCompletedHypertension | Diabetes Type 2United States
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Wuhan Union Hospital, ChinaPeking University First HospitalRecruitingCardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Type 2China
-
Imperial College LondonCompleted
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Second Xiangya Hospital of Central South UniversityRecruitingFibrosis | Scleroderma, Systemic | SemaglutideChina
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, United States, Canada, Poland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Jaeb Center for Health ResearchXeris PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States
-
Jaeb Center for Health ResearchXeris PharmaceuticalsCompleted